RIPK3-mediated necroptosis regulates cardiac allograft rejection

American Journal of Transplantation

Volumn 14, Issue 8, 2014, Pages 1778-1790

  Pavlosky, A ^a,b   Lau, A ^a,b   Su, Y ^a,b   Lian, D ^a   Huang, X ^a   Yin, Z ^a   Haig, A ^b   Jevnikar, A M ^a,b   Zhang, Z X ^a,b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Heart; necroptosis; receptor interacting protein kinase; TNF ; transplantation

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; NECROSTATIN 1; PROTEIN; RAPAMYCIN; RECEPTOR INTERACTING PROTEIN 1; RECEPTOR INTERACTING PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; HMGB1 PROTEIN, MOUSE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, MOUSE; TNFRSF1A PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CARDIAC GRAFT REJECTION; CELL INFILTRATION; CONTROLLED STUDY; GENE DELETION; GRAFT SURVIVAL; HEART TRANSPLANTATION; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE NECROSIS; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL DEATH; CYTOLOGY; ENDOTHELIUM CELL; GRAFT REJECTION; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROCIRCULATION; NECROSIS; PERFUSION; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL DEATH; ENDOTHELIAL CELLS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HMGB1 PROTEIN; INFLAMMATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROCIRCULATION; NECROSIS; PERFUSION; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 84904562812     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12779     Document Type: Article

References (57)

1. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 2012; 31: 1073-1086.
2. Kaczmarek A, Vandenabeele P, Krysko DV., Necroptosis: The release of damage-associated molecular patterns and its physiological relevance. Immunity 2013; 38: 209-223.
3. Vercammen D, Vandenabeele P, Beyaert R, Declercq W, Fiers W., Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells. Cytokine 1997; 9: 801-808.
4. Vercammen D, Beyaert R, Denecker G, et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998; 187: 1477-1485.
5. Suzuki J, Cole SE, Batirel S, et al. Tumor necrosis factor receptor-1 and -2 double deficiency reduces graft arterial disease in murine cardiac allografts. Am J Transplant 2003; 3: 968-976.
6. Al-Lamki RS, Brookes AP, Wang J, et al. TNF receptors differentially signal and are differentially expressed and regulated in the human heart. Am J Transplant 2009; 9: 2679-2696.
7. Ishii D, Schenk AD, Baba S, Fairchild RL., Role of TNFalpha in early chemokine production and leukocyte infiltration into heart allografts. Am J Transplant 2010; 10: 59-68.
8. Lin H, Chensue SW, Strieter RM, et al. Antibodies against tumor necrosis factor prolong cardiac allograft survival in the rat. J Heart Lung Transplant 1992; 11: 330-335.
9. Arbustini E, Grasso M, Diegoli M, et al. Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study. Am J Pathol 1991; 139: 709-715.
10. Imagawa DK, Millis JM, Olthoff KM, et al. Anti-tumor necrosis factor antibody enhances allograft survival in rats. J Surg Res 1990; 48: 345-348.
11. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G., Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11: 700-714.
12. Declercq W, Vanden Berghe T, Vandenabeele P., RIP kinases at the crossroads of cell death and survival. Cell 2009; 138: 229-232.
13. He S, Wang L, Miao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137: 1100-1111.
14. Sun L, Wang H, Wang Z, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012; 148: 213-227.
15. Murphy JM, Czabotar PE, Hildebrand JM, et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013; 39: 443-453.
16. Thapa RJ, Nogusa S, Chen P, et al. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci USA 2013; 110: E3109-E3118.
17. Scaffidi P, Misteli T, Bianchi ME., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195.
18. Takeuchi O, Akira S., Pattern recognition receptors and inflammation. Cell 2010; 140: 805-820.
19. Goldstein DR, Tesar BM, Akira S, Lakkis FG., Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003; 111: 1571-1578.
20. Chen L, Wang T, Zhou P, et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6: 2282-2291.
21. Porrett PM, Yuan X, LaRosa DF, et al. Mechanisms underlying blockade of allograft acceptance by TLR ligands. J Immunol 2008; 181: 1692-1699.
22. Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 1: 112-119.
23. Welz PS, Wullaert A, Vlantis K, et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 2011; 477: 330-334.
24. Roychowdhury S, McMullen MR, Pisano SG, Liu X, Nagy LE., Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 2013; 57: 1773-1783.
25. Smith CC, Davidson SM, Lim SY, Simpkin JC, Hothersall JS, Yellon DM., Necrostatin: A potentially novel cardioprotective agent ? Cardiovasc Drugs Ther 2007; 21: 227-233.
26. Linkermann A, Brasen JH, Himmerkus N, et al. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 2012; 81: 751-761.
27. Oerlemans MI, Liu J, Arslan F, et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Res Cardiol 2012; 107: 270.
28. Lau A, Wang S, Jiang J, et al. RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival. Am J Transplant 2013; 13: 2805-2818.
29. Mannon RB., Necroptosis in solid organ transplantation: A missing link to immune activation ? Am J Transplant 2013; 13: 2785-2786.
30. Mitchell RN., Graft vascular disease: Immune response meets the vessel wall. Annu Rev Pathol 2009; 4: 19-47.
31. Newton K, Sun X, Dixit VM., Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol 2004; 24: 1464-1469.
32. Lim YC, Luscinskas FW., Isolation and culture of murine heart and lung endothelial cells for in vitro model systems. Methods Mol Biol 2006; 341: 141-154.
33. Wuthrich RP, Glimcher LH, Yui MA, Jevnikar AM, Dumas SE, Kelley VE., MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 1990; 37: 783-792.
34. Zhang ZX, Lian D, Huang X, et al. Adoptive transfer of DNT cells induces long-term cardiac allograft survival and augments recipient CD4(+)Foxp3(+) Treg cell accumulation. Transpl Immunol 2011; 24: 119-126.
35. Edwards JR, Diamantakos EA, Peuler JD, Lamar PC, Prozialeck WC., A novel method for the evaluation of proximal tubule epithelial cellular necrosis in the intact rat kidney using ethidium homodimer. BMC Physiol 2007; 7: 1.
36. Zhang ZX, Wang S, Huang X, et al. NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J Immunol 2008; 181: 7489-7498.
37. Albelda SM, Muller WA, Buck CA, Newman PJ., Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule. J Cell Biol 1991; 114: 1059-1068.
38. Xu H, Bickford JK, Luther E, Carpenito C, Takei F, Springer TA., Characterization of murine intercellular adhesion molecule-2. J Immunol 1996; 156: 4909-4914.
39. Ge AZ, Butcher EC., Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-beta ligand. Gene 1994; 138: 201-206.
40. Kitson J, Raven T, Jiang YP, et al. A death-domain-containing receptor that mediates apoptosis. Nature 1996; 384: 372-375.
41. Lewis M, Tartaglia LA, Lee A, et al. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 1991; 88: 2830-2834.
42. Beyer C, Stearns NA, Giessl A, Distler JH, Schett G, Pisetsky DS., The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death. Innate Immun 2012; 18: 727-737.
43. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P., The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 1998; 8: 297-303.
44. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA., Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008; 29: 21-32.
45. Pallet N, Dieude M, Cailhier J, Hebert M., The molecular legacy of apoptosis in transplantation. Am J Transplant 2012; 12: 1378-1384.
46. Ferguson Ta, Choi J, Green Dr,. Armed response: How dying cells influence T-cell functions. Immunol Rev 2011; 241: 77-88.
47. Han W, Xie J, Li L, Liu Z, Hu X., Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis 2009; 14: 674-686.
48. Degterev A, Maki JL, Yuan J., Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ 2013; 20: 366.
49. Degterev A, Hitomi J, Germscheid M, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008; 4: 313-321.
50. Chollet-Martin S, Depoix JP, Hvass U, Pansard Y, Vissuzaine C, Gougerot-Pocidalo MA., Raised plasma levels of tumor necrosis factor in heart allograft rejection. Transplant Proc 1990; 22: 283-286.
51. Micheau O, Tschopp J., Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114: 181-190.
52. Vanden Berghe T, Vanlangenakker N, Parthoens E, et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ 2010; 17: 922-930.
53. Huang Y, Yin H, Han J, et al. Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant 2007; 7: 799-808.
54. He S, Liang Y, Shao F, Wang X., Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci USA 2011; 108: 20054-20059.
55. Kaiser WJ, Sridharan H, Huang C, et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem 2013; 288: 31268-31279.
56. Linkermann A, Heller JO, Prokai A, et al. The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice. J Am Soc Nephrol 2013; 24: 1545-1557.
57. Gardella S, Andrei C, Ferrera D, et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002; 3: 995-1001.